eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications

Placenta Previa

Author: Saju Joy, MD, MS, Assistant Professor, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Wake Forest University School of Medicine
Coauthor(s): Deborah Lyon, MD, Director, Division of Gynecology, Associate Professor, Department of Obstetrics and Gynecology, University of Florida Health Science Center at Jacksonville
Contributor Information and Disclosures

Updated: Aug 12, 2008

Introduction

Background

Placenta previa involves implantation of the placenta over the internal cervical os. Variants include complete implantation over the os (complete placenta previa), a placental edge partially covering the os (partial placenta previa) or the placenta approaching the border of the os (marginal placenta previa). A low-lying placenta implants in the caudad one half to one third of the uterus or within 2-3 cm from the os.

See Medscape's Pregnancy Resource Center.

Pathophysiology

Placental implantation is initiated by the embryo (embryonic plate) adhering in the lower (caudad) uterus. With placental attachment and growth, the developing placenta may cover the cervical os. However, it is thought that a defective decidual vascularization occurs over the cervix, possibly secondary to inflammatory or atrophic changes. As such, sections of the placenta having undergone atrophic changes could persist as a vasa previa. 

A leading cause of third trimester hemorrhage, placenta previa presents classically as painless bleeding. Bleeding is thought to occur in association with the development of the lower uterine segment in the third trimester. Placental attachment is disrupted as this area gradually thins in preparation for the onset of labor. When this occurs, bleeding occurs at the implantation site as the uterus is unable to contract adequately and stop the flow of blood from the open vessels. Thrombin release from the bleeding sites promotes uterine contractions and a vicious cycle of bleeding-contractions-placental separation-bleeding.

Frequency

United States

Placenta previa occurs in 0.3-0.5% of all pregnancies. The risks increase 1.5- to 5-fold with a history of cesarean delivery. With an increased number of cesarean deliveries, this risk can be as great as 10%. Recent studies show that a previous cesarean delivery did not increase the odds of detecting a placenta previa on second-trimester ultrasonography. However, the rate of placental migration observed at 28-36 weeks' gestation may identify patients who are more likely to deliver vaginally with resolution of the previa.

Of all placenta previas, the frequency of complete placenta previa ranges from 20-45%, partial placenta previa accounts for approximately 30%, and marginal placenta previa accounts for the remaining 25-50%.

Mortality/Morbidity

Open table in new window

Table
Morbidities
Relative Risk
Antepartum bleeding10
Need for hysterectomy33
Blood transfusion 10
Septicemia5.5
Thrombophlebitis 5
Morbidities
Relative Risk
Antepartum bleeding10
Need for hysterectomy33
Blood transfusion 10
Septicemia5.5
Thrombophlebitis 5


The perinatal mortality rate associated with placenta previa ranges from 2-3%.

Maternal mortality is 0.03% in the United States.

Race

Placenta previa has no predilection for any race.

Sex

Placenta previa only occurs in pregnant women.

Age

Age is associated with a varying prevalence of placenta previa. The risk of placenta previa in relation to age is as follows:

  • Aged 12-19 years - 1%
  • Aged 20-29 years - 0.33%
  • Aged 30-39 years - 1%
  • Older than 40 years - 2%

Clinical

History

The classic presentation of placenta previa is painless vaginal bleeding.

  • Nearly two thirds of symptomatic patients present before 36 weeks' gestation, with half of these patients presenting before 30 weeks' gestation.
  • This hemorrhage often stops spontaneously and then recurs with labor.

Physical

  • Any pregnant patient beyond the first trimester who presents with vaginal bleeding requires a speculum examination followed by diagnostic ultrasound, unless previous documentation confirms no placenta previa.
  • Because of the risk of provoking life-threatening hemorrhage, a digital examination is absolutely contraindicated until placenta previa is excluded.
  • Uterine activity monitoring reveals that approximately 20% of patients have concurrent contractions with their bleeding.

Causes

  • Hemorrhaging, if associated with labor, would be secondary to cervical dilatation and disruption of the placental implantation from the cervix and lower uterine segment. The lower uterine segment is inefficient in contracting and thus cannot constrict vessels as in the uterine corpus, resulting in continued bleeding.
  • Advancing age (>35)
  • Multiparity
  • Infertility treatment
  • Multiple gestation (larger surface area of the placenta)
  • Erythroblastosis
  • Prior uterine surgery
  • Recurrent abortions
  • Nonwhite ethnicity
  • Low socioeconomic status
  • Short interpregnancy interval
  • Smoking
  • Cocaine use
  • Other causes include digital exam, abruption (pre-eclampsia, chronic hypertension, cocaine use, etc) and other causes of trauma (eg, postcoital trauma).

More on Placenta Previa

Overview: Placenta Previa
Differential Diagnoses & Workup: Placenta Previa
Treatment & Medication: Placenta Previa
Follow-up: Placenta Previa
Multimedia: Placenta Previa
References

References

  1. Bhide A, Prefumo F, Moore J, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. Sep 2003;110(9):860-4. [Medline].

  2. Butler EL, Dashe JS, Ramus RM. Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa. Obstet Gynecol. Jan 2001;97(1):35-8. [Medline].

  3. Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. Apr 2004;190(4):1135-40. [Medline].

  4. Creasy RK, Resnik R, Clark SL. Placenta previa and abruptio placentae. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 1999:616-21.

  5. Cunningham FG, MacDonald PC. Obstetrical hemorrhage. In: Cunningham FG, Gilstrap LC, Gant NF, Leveno KJ, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 20th ed. New York, NY: McGraw-Hill; 1997:755-60.

  6. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med. Mar 2003;13(3):175-90. [Medline].

  7. Gabbe SJ, Benedetti TJ. Obstetric hemorrhage. In: Gabbe SJ, Niebyl JR, Simpson JL, eds. Obstetrics: Normal and Problem Pregnancies. 3rd ed. New York, NY: Churchill Livingstone; 1996:510-5.

  8. Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean deliveries and higher parity. Obstet Gynecol. Jun 2002;99(6):976-80. [Medline].

  9. Harma M, Gungen N, Ozturk A. B-Lynch uterine compression suture for postpartum haemorrhage due to placenta praevia accreta. Aust N Z J Obstet Gynaecol. Feb 2005;45(1):93-5. [Medline].

  10. Hwu YM, Chen CP, Chen HS, Su TH. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG. Oct 2005;112(10):1420-3. [Medline].

  11. Laughon SK, Wolfe HM, Visco AG. Prior cesarean and the risk for placenta previa on second-trimester ultrasonography. Obstet Gynecol. May 2005;105(5 Pt 1):962-5. [Medline].

  12. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. Jul 1997;177(1):210-4. [Medline].

  13. Mustafa SA, Brizot ML, Carvalho MH, et al. Transvaginal ultrasonography in predicting placenta previa at delivery: a longitudinal study. Ultrasound Obstet Gynecol. Oct 2002;20(4):356-9. [Medline].

  14. Oppenheimer L, Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. Mar 2007;29(3):261-73. [Medline].

  15. Ornan D, White R, Pollak J, Tal M. Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet Gynecol. Nov 2003;102(5 Pt 1):904-10. [Medline].

  16. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. Apr 2006;107(4):927-41. [Medline].

  17. Predanic M, Perni SC, Baergen RN, Jean-Pierre C, Chasen ST, Chervenak FA. A sonographic assessment of different patterns of placenta previa "migration" in the third trimester of pregnancy. J Ultrasound Med. Jun 2005;24(6):773-80. [Medline].

  18. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. Sep 2005;193(3 Pt 2):1045-9. [Medline].

  19. Ward CR. Avoiding an incision through the anterior previa at cesarean delivery. Obstet Gynecol. Sep 2003;102(3):552-4. [Medline].

  20. Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. Sep 2006;108(3 Pt 1):573-81. [Medline].

  21. Weinstein A, Chandra P, Schiavello H, Fleischer A. Conservative management of placenta previa percreta in a Jehovah's Witness. Obstet Gynecol. May 2005;105(5 Pt 2):1247-50. [Medline].

  22. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. May 2005;192(5):1458-61. [Medline].

Further Reading

Keywords

placenta previa, complete placenta previa, partial placenta previa, marginal placenta previa, low-lying placenta, placenta accreta, placenta increta, placenta percreta, cesarean delivery, cesarean hysterectomy, transvaginal sonography, transvaginal ultrasonography, tocolysis, continuous fetal monitoring, accreta, increta, percreta, transvaginal ultrasound

Contributor Information and Disclosures

Author

Saju Joy, MD, MS, Assistant Professor, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Wake Forest University School of Medicine
Saju Joy, MD, MS is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Deborah Lyon, MD, Director, Division of Gynecology, Associate Professor, Department of Obstetrics and Gynecology, University of Florida Health Science Center at Jacksonville
Deborah Lyon, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of American Medical Colleges, Association of Professors of Gynecology and Obstetrics, and Florida Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Ronald Levine, MD, Director, Section of Gynecologic Endoscopy, Professor, Department of Obstetrics and Gynecology, University of Louisville School of Medicine
Ronald Levine, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Obstetricians and Gynecologists, American Medical Association, and Society of Laparoendoscopic Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Richard S Legro, MD, Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Pennsylvania State University College of Medicine; Consulting Staff, Milton S Hershey Medical Center
Richard S Legro, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Endocrine Society, Phi Beta Kappa, and Society of Reproductive Surgeons
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Carl V Smith, MD, The Distinguished Chris J and Marie A Olson Chair of Obstetrics and Gynecology, Professor, Department of Obstetrics and Gynecology, University of Nebraska Medical Center
Carl V Smith, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Arkansas Medical Society, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Council of University Chairs of Obstetrics and Gynecology, Nebraska Medical Association, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.